N6-Cyclopentyladenosine
SIGMA/C8031 - solid
Synonym: CPA
CAS Number: 41552-82-3
Empirical Formula (Hill Notation): C15H21N5O4
Molecular Weight: 335.36
MDL Number: MFCD00036845
Linear Formula: C15H21N5O4
Product Type: Chemical
| color | white to off-white |
| form | solid |
| InChI | 1S/C15H21N5O4/c21-5-9-11( |
| InChI key | SQMWSBKSHWARHU-SDBHATRESA |
| Quality Level | 200 ![]() |
500 ![]() |
|
| SMILES string | OC[C@H]1O[C@H]([C@H](O)[C |
| solubility | 0.1 M HCl: 12 mg/mL |
| DMSO: 23 mg/mL | |
| H2O: 1.7 mg/mL | |
| storage temp. | 2-8°C |
| Application: | N6-Cyclopentyladenosine has also been used to study its effect on p53 and caspase 3, 8, and 9 expression and apoptosis rate in MCF-7 breast cancer cell line. |
| Application: | N6-Cyclopentyladenosine has been used to study its effect on the cavernosal smooth muscle cells from lean and db/db (obesity and type II diabetes caused by a leptin receptor mutation) mice. |
| Biochem/physiol Actions: | N6-Cyclopentyladenosine (CPA) is an adenosine derivative and a potent A1 adenosine receptor agonist. It acts as an anticonvulsant and might exhibit protective actions against aminophylline (AMPH)-induced seizures. |
| Biochem/physiol Actions: | N6-Cyclopentyladenosine also exhibits analgesic effect against acute, arthritis-induced and neuropathic pain. |
| Features and Benefits: | This compound is featured on the Adenosine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 100 mg in glass bottle |
| Packaging: | 25 mg in poly bottle |
| Physical form: | hygroscopic solid |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

